Analysis of early viral kinetics in chronic hepatitis C genotype 2 or 3 patients treated with peginterferon Alpha-2a and ribavirin

被引：0
|
作者：
Scherzer, Thomas-Matthias
Staufer, Katharina
Steindl-Munda, Petra
Holzmann, Heidemarie
Ferenci, Peter
机构：
来源：
GASTROENTEROLOGY | 2007年 / 132卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：A789 / A789
页数：1
相关论文
共 50 条
  • [41] Early viral kinetics during treatment with low doses of peginterferon alfa-2a and ribavirin in patients with chronic hepatitis C infected with genotypes 2 and 3
    Bozorg, B
    Neumann, AU
    Heller, T
    Ghany, M
    Kleiner, DE
    Pawlotsky, JM
    Zeuzem, S
    Schalm, SW
    Lutchman, G
    Park, Y
    Rymer, C
    Liang, TJ
    Hoofnagle, JH
    HEPATOLOGY, 2004, 40 (04) : 340A - 340A
  • [42] Peginterferon alpha-2A plus ribavirin versus peginterferon alpha-2B plus ribavirin in naive patients with chronic hepatitis C virus infection: Results of a prospective randomised trial
    Ascione, A.
    De Luca, M.
    Tartaglione, M. T.
    Lampasi, E.
    Lanza, A. Galeota
    Picciotto, F. P.
    Di Costanzo, G. G.
    Leandro, G.
    JOURNAL OF HEPATOLOGY, 2008, 48 : S370 - S370
  • [43] Early predictors of hemoglobin reduction during first four weeks of peginterferon alpha-2a/ribavirin therapy in chronic hepatitis C
    Spangler, Chad
    Han, Samuel
    Kwasny, Mary Morrissey
    Cohen, Stanley
    Reau, Nancy
    Jensen, Donald
    GASTROENTEROLOGY, 2006, 130 (04) : A844 - A844
  • [44] Impact of early viral kinetics on pegylated interferon alpha 2b plus ribavirin therapy in Japanese patients with genotype 2 chronic hepatitis C
    Nomura, H.
    Miyagi, Y.
    Tanimoto, H.
    Ishibashi, H.
    JOURNAL OF VIRAL HEPATITIS, 2009, 16 (05) : 346 - 351
  • [45] Efficacy of re-treatment by peginterferon alpha-2a and ribavirin in a child with hepatitis C
    Nishimata, Shigeo
    Tsutsumi, Norito
    Suzuki, Shunsuke
    Nagao, Ryuhei
    Kashiwagi, Yasuyo
    Kawashima, Hisashi
    JOURNAL OF INFECTION AND CHEMOTHERAPY, 2014, 20 (7-8) : 443 - 445
  • [46] Peginterferon alpha-2b vs peginterferon alpha-2a in the treatment of chronic hepatitis C infection
    Hammoud, Ihab
    Sherbondy, Mary Ann H.
    Moonka, Dilip
    Gordon, Stuart C.
    Guevara, Rodolfo
    Brown, Kimberly
    HEPATOLOGY, 2007, 46 (04) : 386A - 387A
  • [47] The effectiveness of retreatment with peginterferon alfa and ribavirin in patients with chronic viral hepatitis C genotype 2 and 3: a prospective cohort study in Brazil
    Simara Artico
    Karine Medeiros Amaral
    Candice Beatriz Treter Gonçalves
    Paulo Dornelles Picon
    BMC Infectious Diseases, 12
  • [48] The effectiveness of retreatment with peginterferon alfa and ribavirin in patients with chronic viral hepatitis C genotype 2 and 3: a prospective cohort study in Brazil
    Artico, Simara
    Amaral, Karine Medeiros
    Treter Goncalves, Candice Beatriz
    Picon, Paulo Dornelles
    BMC INFECTIOUS DISEASES, 2012, 12
  • [49] Highly effective peginterferon alpha-2a plus ribavirin combination therapy for chronic hepatitis C in hemophilia in Korea
    Yang, Suh Yoon
    Lee, Hyun Woong
    Lee, Youn Jae
    Park, Sung Jae
    Yoo, Ki Young
    Kim, Hyung Joon
    CLINICAL AND MOLECULAR HEPATOLOGY, 2015, 21 (02) : 125 - 130
  • [50] Viral kinetics in genotype 1 chronic hepatitis C patients during therapy with 2 different doses of peginterferon alfa-2b plus ribavirin
    Buti, M
    Sanchez-Avila, F
    Lurie, Y
    Stalgis, C
    Valdés, A
    Martell, M
    Esteban, R
    HEPATOLOGY, 2002, 35 (04) : 930 - 936
12345